SBI Securities
ZNTL icon

SBI Securities’s Zentalis Pharmaceuticals ZNTL Stock Holding History

SBI Securities’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$352 Buy
127
+100
+370% +$403 ﹤0.01% 3228
2026
Q2 		$131 Hold
27
– – ﹤0.01% 3447
2026
Q1 		$63 Hold
27
– – ﹤0.01% 3531
2025
Q4 		$36 Sell
27
-1
-4% -$1 ﹤0.01% 3648
2025
Q3 		$42 Buy
28
+1
+4% +$1 ﹤0.01% 3766
2025
Q2 		$31 Hold
27
– – ﹤0.01% 3825
2025
Q1 		$43 Hold
27
– – ﹤0.01% 3689
2024
Q4 		$82 Buy
+27
New +$88 ﹤0.01% 3518

Other funds holding ZNTL

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DLK Investment Management
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
Investment Research & Advisory Group
Investment Research & Advisory Group Atlanta, Georgia $337M AUM 19.8% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities's ZNTL Position: Q3 2026 in Review

SBI Securities increased its Zentalis Pharmaceuticals (ZNTL) stake by 370% in Q3 2026, buying an estimated $403 and bringing the position to 127 shares worth $352. The position accounts for ﹤0.01% of the portfolio, ranked #3228.

SBI Securities first reported a position in ZNTL in Q4 2024 and has held it in 8 quarters since. 12 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

  • SBI Securities held 127 shares of Zentalis Pharmaceuticals worth $352 as of Q3 2026.
  • SBI Securities bought 100 Zentalis Pharmaceuticals shares in Q3 2026, an estimated $403.
  • Zentalis Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3228 holding.
  • SBI Securities first reported a position in Zentalis Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 12 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.